Related Experiment Videos

Comprehensive treatment for primary liver cancer

Guang-Shun Yang¹, Zhi-Quan Wu, Meng-Chao Wu

¹Eastern Hepatobiliary Hospital, Second Military Medical University, Shanghai 200438, China. gs_yang00@yahoo.com

Hepatobiliary & Pancreatic Diseases International : HBPD INT

|November 6, 2003

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Cidan Capsule in Combination with Adjuvant Transarterial Chemoembolization Reduces Recurrence Rate after Curative Resection of Hepatocellular Carcinoma: A Multicenter, Randomized Controlled Trial.

Chinese journal of integrative medicine·2022

Hepatocyte-derived VEGFA accelerates the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via activating hepatic stellate cells.

Acta pharmacologica Sinica·2022

Integrated Bioinformatics Analysis and Validation of the Prognostic Value of RBM10 Expression in Hepatocellular Carcinoma.

Cancer management and research·2022

A new staging system for hepatocellular carcinoma associated with portal vein tumor thrombus.

Hepatobiliary surgery and nutrition·2022

Patterns, treatments, and prognosis of tumor recurrence after resection for hepatocellular carcinoma with microvascular invasion: a multicenter study from China.

HPB : the official journal of the International Hepato Pancreato Biliary Association·2021

Mesoporous Silica Nanoparticles for Potential Immunotherapy of Hepatocellular Carcinoma.

Frontiers in bioengineering and biotechnology·2021

See all related articles